Observational study

( DrugBank: - / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	66

告示番号	疾患名（ページ内リンク）	臨床試験数
271	強直性脊椎炎	12

46. 悪性関節リウマチ

臨床試験数 : 4,356 / 薬物数 : 2,567 - (DrugBank : 415) / 標的遺伝子数 : 192 - 標的パスウェイ数 : 228

trials per page:

Showing 1 to 10 of 66 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05375942 (ClinicalTrials.gov)	November 11, 2022	11/5/2022	This is a Retrospective Observational StudyLooking at the Characteristics and Outcomes of Participan ...	Characteristics and 6-month Outcomes Among Real-World Rheumatoid Arthritis Patients Initiating Infle ...	Arthritis, Rheumatoid	Drug: Inflectra	Pfizer	NULL	Completed	18 Years	N/A	All	255		United States
2	NCT05323591 (ClinicalTrials.gov)	May 3, 2022	5/4/2022	Prospective Observational Studyof Filgotinib in Female Participants With Rheumatoid Arthritis in Fra ...	A Prospective, Non-interventional Studyin Female Patients With Moderate to Severe Active Rheumatoid ...	Rheumatoid Arthritis	Drug: Filgotinib	Galapagos NV	NULL	Recruiting	18 Years	N/A	Female	150		France
3	NCT05424393 (ClinicalTrials.gov)	March 4, 2022	15/6/2022	Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients	Long-term Real-world Prospectiv Observational Studyon Maintenance Treatment With YISAIPU, an Etanerc ...	Rheumatoid Arthritis	Drug: YISAIPU® ( An etanercept biosimilar);Drug: csDMARDs	The First Affiliated Hospital of Xiamen University	NULL	Recruiting	18 Years	75 Years	All	500		China
4	NCT05240859 (ClinicalTrials.gov)	February 22, 2022	6/2/2022	Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis	A Multicenter, Prospective, ObservationalReal World StudyFor the Efficacy and Safety of a Adalimumab ...	Rheumatoid Arthritis	Drug: Geleli	Peking University People's Hospital	NULL	Not yet recruiting	N/A	N/A	All	1600		China
5	NCT04871919 (ClinicalTrials.gov)	May 11, 2021	29/4/2021	Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis	A Prospective, Non-interventional Studyof the Effectiveness, Safety, and Health Related Outcomes in ...	Rheumatoid Arthritis	Drug: Filgotinib	Galapagos NV	NULL	Recruiting	18 Years	N/A	All	1500		Belgium;Germany;Italy;Netherlands;Spain;United Kingdom
6	ChiCTR2100050865	2020-07-18	2021-09-05	Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab ...	A multicenter, prospective, observational studyto evaluate the efficacy and safety of Tripterygium w ...	rheumatoid arthritis	Group 1:Tripterygium wilfordii polyglycoside tablets + Adamu monoclonal antibody;Group 2:Methotrexat ...	The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine	NULL	Recruiting	18	80	Both	Group 1:30;Group 2:30;	Phase 4	China
7	ITMCTR2100005277	2020-07-18	2021-09-05	Observation on the efficacy of Tripterygium wilfordii polyglycosides tablets combined with Adamumab ...	A multicenter, prospective, observational studyto evaluate the efficacy and safety of Tripterygium w ...	rheumatoid arthritis	1:Tripterygium wilfordii polyglycoside tablets + Adamu monoclonal antibody;2:Methotrexate tablets + ...	The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine	NULL	Recruiting	18	80	Both	1:30;2:30;	Phase 4	China
8	NCT04449224 (ClinicalTrials.gov)	April 27, 2020	7/6/2020	Comparative Effectiveness of Targeted Therapy in RA Patients	Comparative Effectiveness of Biologic Disease-modifying Antirheumatic Drugs and Small Molecular Inhi ...	Rheumatoid Arthritis	Drug: Adalimuab, Etanercept, Tocilizumab, or Abatacept;Drug: Tofacitinib or Baricitinib	Hanyang University	Ministry of Health, Republic of Korea	Recruiting	19 Years	N/A	All	506		Korea, Republic of
9	ChiCTR1900021686	2019-03-15	2019-03-05	A observational studyfor iguratimod combined with methotrexate in remission or reversion bone erosio ...	A observational studyfor iguratimod combined with methotrexate in remission or reversion bone erosio ...	Rheumatoid arthritis	Case Series:IGU combined with MTX ;	Nanjing Drum Tower Hospital	NULL	Pending	18	70	Both	Case Series:30;	Phase 4	China
10	NCT03636984 (ClinicalTrials.gov)	August 24, 2018	13/8/2018	Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World	Efficacy and Safety Studyof Anbainuo in Chinese Patients With Rheumatoid Arthritis/ Ankylosing Spond ...	Rheumatoid Arthritis;Ankylosing Spondylitis	Drug: recombinant TNF-a receptor: IgG Fc fusion protein	Zhejiang Hisun Pharmaceutical Co. Ltd.	NULL	Not yet recruiting	18 Years	N/A	All	1000		NULL

First Previous1 2 3 4 5 6 7Next Last

271. 強直性脊椎炎

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

trials per page:

Showing 1 to 10 of 12 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100054201	2022-01-01	2021-12-11	Effectiveness and Economic Evaluation of Intervention in Chinese Patients with Active Ankylosing Spo ...	Effectiveness and Economic Evaluation of Intervention in Chinese Patients with Active Ankylosing Spo ...	Ankylosing Spondylitis	Intervention group:Etanercept 25mg each time, twice a week, with an interval of 3-4 days;Control gro ...	West China Hospital of Sichuan University	NULL	Recruiting			Both	Intervention group:3000;Control group:1000;	N/A	China
2	NCT03839862 (ClinicalTrials.gov)	January 1, 2019	11/2/2019	Faecal Analyses in Spondyloarthritis Therapy	Faecal Analyses in Spondyloarthritis Therapy: A Prospective Observational Studyof the Intestinal Mic ...	Spondyloarthropathies;Ankylosing Spondylitis	Drug: TNF-inhibition	Region Skane	NULL	Recruiting	18 Years	N/A	All	50		Sweden
3	NCT03636984 (ClinicalTrials.gov)	August 24, 2018	13/8/2018	Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World	Efficacy and Safety Studyof Anbainuo in Chinese Patients With Rheumatoid Arthritis/ Ankylosing Spond ...	Rheumatoid Arthritis;Ankylosing Spondylitis	Drug: recombinant TNF-a receptor: IgG Fc fusion protein	Zhejiang Hisun Pharmaceutical Co. Ltd.	NULL	Not yet recruiting	18 Years	N/A	All	1000		NULL
4	NCT03470688 (ClinicalTrials.gov)	March 1, 2018	6/3/2018	Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents	An Observational StudyDesigned to Investigate the Utilisation and Effectiveness of Originator and Bi ...	Rheumatoid Arthritis;Psoriatic Arthritis;Ankylosing Spondylitis	Biological: Originator;Biological: Biosimilar	Opal Rheumatology Ltd.	Merck Sharp & Dohme Corp.	Recruiting	18 Years	N/A	All	5000		Australia
5	NCT03557853 (ClinicalTrials.gov)	June 2016	5/6/2018	Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated ...	A Prospective Observational Studyto Evaluate Clinical and Radiological Manifestations of Coxitis in ...	Ankylosing Spondylitis;Coxitis	Drug: Golimumab Injection	MSD Pharmaceuticals LLC	NULL	Unknown status	18 Years	N/A	All	39		Russian Federation
6	NCT02750800 (ClinicalTrials.gov)	April 7, 2016	13/4/2016	Post-marketing Observational Studyto Evaluate the Incremental Impact of AbbVie's Patient Support Pro ...	Post-marketing Observational Studyto Evaluate the Effect of HUMIRA (Adalimumab) Treatment With AbbVi ...	Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis;Psoriasis;Crohn's Disease;Ulcerative ...	Biological: Adalimumab;Behavioral: AbbVie Care 2.0	AbbVie	NULL	Completed	18 Years	99 Years	All	427		Hungary
7	NCT02605642 (ClinicalTrials.gov)	September 10, 2015	2/9/2015	Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who ...	PERSIST: PROSPECTIVE OBSERVATIONALCOHORT STUDYTO ASSESS PERSISTENCE OF CT-P13 (INFLIXIMAB) IN PATIEN ...	Rheumatoid Diseases;Rheumatoid Arthritis;Ankylosing Spondylitis;Psoriatic Arthritis	Drug: CT-P13	Pfizer	Hospira, now a wholly owned subsidiary of Pfizer	Completed	18 Years	N/A	All	351		Bulgaria;Canada;Czechia;Germany;Greece;Spain;United Kingdom;Czech Republic;France;Italy
8	NCT02293681 (ClinicalTrials.gov)	April 10, 2015	14/11/2014	An Observational Studyof Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip I ...	A Multicenter and Observational Studyto Assess the Effectiveness of Infliximab Comparing With Conven ...	Spondylitis, Ankylosing	Drug: Infliximab;Drug: NSAIDs;Drug: DMARDs	Janssen Research & Development, LLC	NULL	Terminated	16 Years	40 Years	All	76	N/A	China
9	NCT01793285 (ClinicalTrials.gov)	December 2010	30/1/2013	An Observational, Retrospective, Multicenter, National Studyfor the Monitoring of Subjects Who Parti ...	Retrospective, Multicentric, National, Observational Study, to Follow-up the Patients Who Participat ...	Ankylosing Spondylitis	Drug: ETANERCEPT	Pfizer	NULL	Completed	18 Years	N/A	All	85	N/A	Spain
10	NCT01188655 (ClinicalTrials.gov)	May 2008	24/8/2010	ObservationalNon-Interventional StudyWith Enbrel (Etanercept) in Patients With Ankylosing Spondyliti ...	Observational Non-Interventional Study With Enbrel in Patients With Ankylosing Spondylitis	Spondylitis, Ankylosing	Drug: Enbrel	Pfizer	NULL	Completed	18 Years	N/A	All	89	N/A	NULL

First Previous1 2Next Last